AAAAI Statements
February 25, 2026
Vaccine recommendations from the American Academy of Pediatrics (AAP) are designed to help children in the United States build immunity against serious diseases so they can stay healthy and our communities can stay healthy. AAP continues to recommend routine immunization for RSV, hepatitis A, hepatitis B, rotavirus, flu and meningococcal disease. If you have questions about vaccines, talk with your child’s pediatrician. Working together, you can make informed decisions about your child’s health.
AAAAI Opposes Repeal of Endangerment Finding
February 13, 2026
Following an announcement by President Donald Trump and the U.S. Environmental Protection Agency (EPA) to move forward with repealing the Endangerment Finding— which established that greenhouse gas emissions endanger public health—the American Academy of Allergy, Asthma & Immunology (AAAAI) issued the following statement:
The American Academy of Allergy, Asthma & Immunology (AAAAI) opposes the proposal to repeal the Endangerment Finding, which is based on decades of scientific evidence demonstrating that greenhouse gas emissions contribute to environmental changes that adversely affect human health.
The proposed action disregards a substantial body of peer-reviewed science linking greenhouse gas–driven climate change to worsening asthma and allergic disease outcomes. Extensive research published in the AAAAI family of journals: The Journal of Allergy and Clinical Immunology (JACI) and The Journal of Allergy and Clinical Immunology: In Practice (JACI: In Practice) and The Journal of Allergy and Clinical Immunology: Global (JACI: Global) shows that rising temperatures and increasing atmospheric carbon dioxide levels are associated with increased aeroallergen exposure and decreased air quality that negatively affect asthma control and allergic disease burden.
Science-based regulation of greenhouse gas emissions is an important public health measure that supports evidence-based care in allergy, asthma and immunology. Weakening these protections increases preventable risk for patients and undermines efforts to protect respiratory and allergic health now and in the future.
“The Endangerment Finding reflects a broad and enduring scientific consensus that greenhouse gas emissions pose a risk to human health,” said AAAAI President Frank Virant, MD, FAAAAI. “Weakening that foundation has negative consequences for patient care and public health, which is why it is important that environmental decisions remain based on established science.”
The AAAAI has a history of endorsing legislation that supports clean air. Recently, the AAAAI wrote in support of the Public Health Air Quality Act (H.R.6782/S.3529), which would require the EPA to deploy fenceline air quality monitoring for pollutants contributing to poor health outcomes—including asthma—across vulnerable populations.
The AAAAI will continue to advance evidence-based policies and scientific research that protect patients with asthma and allergic and immunologic diseases and support clean air as a fundamental component of public health.
2/25/2026